BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33852445)

  • 1. Diagnostic Performance of Hemophagocytic Lymphohistiocytosis Criteria and HScore in Critically Ill Patients With Severe Hemophagocytic Syndrome.
    Valade S; Monseau G; Mariotte E; Darmon M
    Crit Care Med; 2021 Sep; 49(9):e874-e879. PubMed ID: 33852445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore.
    Knaak C; Nyvlt P; Schuster FS; Spies C; Heeren P; Schenk T; Balzer F; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
    Crit Care; 2020 May; 24(1):244. PubMed ID: 32448380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperferritinemia in Critically Ill Patients.
    Lachmann G; Knaak C; Vorderwülbecke G; La Rosée P; Balzer F; Schenk T; Schuster FS; Nyvlt P; Janka G; Brunkhorst FM; Keh D; Spies C
    Crit Care Med; 2020 Apr; 48(4):459-465. PubMed ID: 32205591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Performance of Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
    Meena NK; Sinokrot O; Duggal A; Alpat D; Singh ZN; Coviello JM; Li M; Wang X; Mireles-Cabodevila E
    J Intensive Care Med; 2020 Dec; 35(12):1476-1482. PubMed ID: 30862243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.
    Fardet L; Galicier L; Lambotte O; Marzac C; Aumont C; Chahwan D; Coppo P; Hejblum G
    Arthritis Rheumatol; 2014 Sep; 66(9):2613-20. PubMed ID: 24782338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for Early Diagnosis of Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
    Debaugnies F; Mahadeb B; Nagant C; Meuleman N; De Bels D; Wolff F; Gottignies P; Salaroli A; Borde P; Voué M; Corazza F
    J Clin Immunol; 2021 Apr; 41(3):658-665. PubMed ID: 33417087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Ferritin to Identify Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis.
    Grangé S; Buchonnet G; Besnier E; Artaud-Macari E; Beduneau G; Carpentier D; Dehay J; Girault C; Marchalot A; Guerrot D; Tamion F
    Crit Care Med; 2016 Nov; 44(11):e1045-e1053. PubMed ID: 27441901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients.
    Nyvlt P; Schuster FS; Ihlow J; Heeren P; Spies C; Hiesgen J; Schenk T; von Brünneck AC; Westermann J; Brunkhorst FM; La Rosée P; Janka G; Lachmann C; Lachmann G
    Eur J Haematol; 2024 Jun; 112(6):917-926. PubMed ID: 38368850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the HScore and the HLH-2004 diagnostic criteria for the diagnosis of hemophagocytic lymphohistiocytosis in a multicenter cohort.
    Bilston L; Croden J; Taparia M; Karkhaneh M; Grossman J; Sun HL
    Eur J Haematol; 2022 Aug; 109(2):129-137. PubMed ID: 35434872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe COVID-19-associated hyperinflammatory syndrome versus classic hemophagocytic lymphohistiocytosis: similarities, differences, and the way forward.
    Yadav G; Malhotra H; Mehta P; Sachu R; Rizvi I; Bharti VR; Kumar M; Kumar N; Ali W; Verma SP; Puri B; Dandu H
    J Investig Med; 2023 Mar; 71(3):244-253. PubMed ID: 36803041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU.
    Cui Y; Zhang YC; Kang YL; Ren YQ; Miao HJ; Wang F
    Pediatr Crit Care Med; 2016 Oct; 17(10):e437-e443. PubMed ID: 27487914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and Mortality of Hemophagocytic Lymphohistiocytosis in Adult Critically Ill Patients: A Systematic Review With Pooled Analysis.
    Knaak C; Schuster FS; Nyvlt P; Spies C; Feinkohl I; Beutel G; Schenk T; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
    Crit Care Med; 2020 Nov; 48(11):e1137-e1146. PubMed ID: 32947471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic Lymphohistiocytosis in a PICU of a Developing Economy: Clinical Profile, Intensive Care Needs, Outcome, and Predictors of Mortality.
    Parajuli B; Angurana SK; Awasthi P; Nallasamy K; Baranwal A; Bansal A; Bansal D; Rawat A; Varma N; Jayashree M
    Pediatr Crit Care Med; 2021 Jan; 22(1):e44-e57. PubMed ID: 33031348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
    Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
    Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome analysis of pediatric hemophagocytic lymphohistiocytosis.
    Chen TY; Hsu MH; Kuo HC; Sheen JM; Cheng MC; Lin YJ
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):172-179. PubMed ID: 32307323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
    Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
    BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofibrinogenemia Is Associated With Poor Outcome and Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in Pediatric Severe Sepsis.
    Signoff JK; Fitzgerald JC; Teachey DT; Balamuth F; Weiss SL
    Pediatr Crit Care Med; 2018 May; 19(5):397-405. PubMed ID: 29470247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis.
    Zoref-Lorenz A; Murakami J; Hofstetter L; Iyer S; Alotaibi AS; Mohamed SF; Miller PG; Guber E; Weinstein S; Yacobovich J; Nikiforow S; Ebert BL; Lane A; Pasvolsky O; Raanani P; Nagler A; Berliner N; Daver N; Ellis M; Jordan MB
    Blood; 2022 Feb; 139(7):1098-1110. PubMed ID: 34780598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases.
    Batu ED; Erden A; Seyhoğlu E; Kilic L; Büyükasık Y; Karadag O; Bilginer Y; Bilgen SA; Akdogan A; Kiraz S; Ertenli AI; Özen S; Kalyoncu U
    Scand J Rheumatol; 2017 Jan; 46(1):44-48. PubMed ID: 27359073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.